Significant Treatment Attrition Rate Seen in Multiple Myeloma
In patients receiving autologous stem cell transplant, 57.6 percent advanced to second-line treatment, 32.6 percent to third-line
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.